These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 17094561)
21. Initial experience with imaging-guided intramuscular botulinum toxin injection in patients with idiopathic cervical dystonia. Lee IH; Yoon YC; Sung DH; Kwon JW; Jung JY AJR Am J Roentgenol; 2009 Apr; 192(4):996-1001. PubMed ID: 19304706 [TBL] [Abstract][Full Text] [Related]
22. Evidence-based medicine in botulinum toxin therapy for cervical dystonia. Ceballos-Baumann AO J Neurol; 2001 Apr; 248 Suppl 1():14-20. PubMed ID: 11357233 [TBL] [Abstract][Full Text] [Related]
23. Low-dose botulinum toxin-a treatment of cervical dystonia - a double-blind, randomized pilot study. Laubis-Herrmann U; Fries K; Topka H Eur Neurol; 2002; 47(4):214-21. PubMed ID: 12037435 [TBL] [Abstract][Full Text] [Related]
24. Jaw-opening oromandibular dystonia secondary to Wilson's disease treated with botulinum toxin type A. Teive HA; Klüppel LE; Munhoz RP; Becker N; Müller PR; Werneck LC Arq Neuropsiquiatr; 2012 Jun; 70(6):407-9. PubMed ID: 22699536 [TBL] [Abstract][Full Text] [Related]
25. Medical Updates in Management of Hypertonia. Dy R; Roge D Phys Med Rehabil Clin N Am; 2020 Feb; 31(1):57-68. PubMed ID: 31760994 [TBL] [Abstract][Full Text] [Related]
26. Botulinum toxin type A (Botox) for the neuromuscular correction of excessive gingival display on smiling (gummy smile). Polo M Am J Orthod Dentofacial Orthop; 2008 Feb; 133(2):195-203. PubMed ID: 18249285 [TBL] [Abstract][Full Text] [Related]
27. [Botulinum A toxin treatment in patients with oromandibular dystonia with concomitant malnutrition]. Budrewicz S; Koszewicz M; Góral M Neurol Neurochir Pol; 2003; 37 Suppl 5():55-60. PubMed ID: 15098332 [TBL] [Abstract][Full Text] [Related]
28. Long-term remission of idiopathic cervical dystonia after treatment with botulinum toxin. Giladi N; Meer J; Kidan H; Honigman S Eur Neurol; 2000; 44(3):144-6. PubMed ID: 11053961 [TBL] [Abstract][Full Text] [Related]
29. [Botulinum A toxin in the treatment of focal dystonias]. Domzał TM Neurol Neurochir Pol; 1998; 32 Suppl 1():35-44. PubMed ID: 9608551 [TBL] [Abstract][Full Text] [Related]
31. Specific characteristics of the medical history of swallowing before and after application of botulinum toxin in patients with cervical dystonia. Vilanova TFDD; Borges V; Ferraz HB Clinics (Sao Paulo); 2019 Apr; 74():e776. PubMed ID: 30942281 [TBL] [Abstract][Full Text] [Related]
32. BTX-A has notable effects contradicting some treatment aims in the rat triceps surae compartment, which are not confined to the muscles injected. Yucesoy CA; Ateş F J Biomech; 2018 Jan; 66():78-85. PubMed ID: 29154085 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of botulinum toxin A therapy in children with adductor spasm by gross motor function measure. Mall V; Heinen F; Kirschner J; Linder M; Stein S; Michaelis U; Bernius P; Lane M; Korinthenberg R J Child Neurol; 2000 Apr; 15(4):214-7. PubMed ID: 10805185 [TBL] [Abstract][Full Text] [Related]
34. Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group. Kessler KR; Skutta M; Benecke R J Neurol; 1999 Apr; 246(4):265-74. PubMed ID: 10367694 [TBL] [Abstract][Full Text] [Related]
36. Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Grosse J; Kramer G; Stöhrer M Eur Urol; 2005 May; 47(5):653-9. PubMed ID: 15826758 [TBL] [Abstract][Full Text] [Related]